MannKind Corporation Company Profile (NASDAQ:MNKD)

About MannKind Corporation (NASDAQ:MNKD)

MannKind Corporation logoMannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control. AFREZZA consists of a dry formulation of human insulin delivered from a portable inhaler. AFREZZA utilizes its Technosphere formulation technology. Technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics. Technosphere powders are based on the Company's fumaryl diketopiperazine (FDKP), which is a potential of Hydrogen (pH)-sensitive organic molecule that self-assembles into small particles under acidic conditions. The Company has also created a range of breath-powered, dry powder inhalers. Its inhalers can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: Biotechnology
  • Symbol: NASDAQ:MNKD
  • CUSIP: 56400P20
  • Web: www.mannkindcorp.com
Capitalization:
  • Market Cap: $239.72 million
  • Outstanding Shares: 104,683,000
Average Prices:
  • 50 Day Moving Avg: $1.61
  • 200 Day Moving Avg: $1.46
  • 52 Week Range: $0.67 - $4.34
P/E:
  • Trailing P/E Ratio: 1.72
  • Foreward P/E Ratio: Infinity
  • P/E Growth: -0.09
Sales & Book Value:
  • Annual Revenue: $179.93 million
  • Price / Sales: 1.33
  • Book Value: ($2.12) per share
  • Price / Book: -1.08
Profitability:
  • EBIDTA: $60.33 million
  • Net Margins: 71.60%
  • Return on Equity: -24.93%
  • Return on Assets: 57.11%
Debt:
  • Debt-to-Equity Ratio: -0.48%
  • Current Ratio: 0.59%
  • Quick Ratio: 0.56%
Misc:
  • Average Volume: 2.57 million shs.
  • Beta: 3.16
  • Short Ratio: 13.18
 

Frequently Asked Questions for MannKind Corporation (NASDAQ:MNKD)

What is MannKind Corporation's stock symbol?

MannKind Corporation trades on the NASDAQ under the ticker symbol "MNKD."

How were MannKind Corporation's earnings last quarter?

MannKind Corporation (NASDAQ:MNKD) released its quarterly earnings data on Monday, August, 7th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.10. The firm had revenue of $2.16 million for the quarter, compared to analyst estimates of $2.75 million. MannKind Corporation had a net margin of 71.60% and a negative return on equity of 24.93%. During the same period in the previous year, the business posted $0.08 EPS. View MannKind Corporation's Earnings History.

When will MannKind Corporation make its next earnings announcement?

MannKind Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, November, 8th 2017. View Earnings Estimates for MannKind Corporation.

Where is MannKind Corporation's stock going? Where will MannKind Corporation's stock price be in 2017?

3 analysts have issued twelve-month price objectives for MannKind Corporation's shares. Their predictions range from $0.83 to $1.00. On average, they expect MannKind Corporation's share price to reach $0.92 in the next year. View Analyst Ratings for MannKind Corporation.

Who are some of MannKind Corporation's key competitors?

Who are MannKind Corporation's key executives?

MannKind Corporation's management team includes the folowing people:

  • Kent Kresa, Chairman of the Board
  • Michael E. Castagna Pharm.D., Chief Executive Officer, Director
  • Rosabel R. Alinaya, Acting Chief Financial Officer, Senior Vice President, Chief Accounting Officer
  • Steven B Binder, Chief Financial Officer, Principal Accounting Officer
  • Linda Adreveno, Senior Vice President - Human Resources
  • Joseph Kocinsky, Chief Technology Officer, Corporate Vice President
  • David B. Thomson Ph.D., J.D., Corporate Vice President, General Counsel, Corporate Secretary
  • Raymond W. Urbanski M.D. Ph.D., Corporate Vice President, Chief Medical Officer
  • Patrick McCauley J.D., Chief Commercial Officer
  • Stuart A. Tross Ph.D., Chief People Officer

Who owns MannKind Corporation stock?

MannKind Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (2.51%), Harel Insurance Investments & Financial Services Ltd. (0.58%), Balyasny Asset Management LLC (0.38%), GSA Capital Partners LLP (0.34%), Northern Trust Corp (0.26%) and LMR Partners LLP (0.25%). Company insiders that own MannKind Corporation stock include Matthew J Pfeffer, Michael Castagna, Raymond W Urbanski and Rosabel Realica Alinaya. View Institutional Ownership Trends for MannKind Corporation.

Who sold MannKind Corporation stock? Who is selling MannKind Corporation stock?

MannKind Corporation's stock was sold by a variety of institutional investors in the last quarter, including Northern Trust Corp, Vanguard Group Inc., GSA Capital Partners LLP, Bank of New York Mellon Corp, Virtu KCG Holdings LLC and Schwab Charles Investment Management Inc.. View Insider Buying and Selling for MannKind Corporation.

Who bought MannKind Corporation stock? Who is buying MannKind Corporation stock?

MannKind Corporation's stock was bought by a variety of institutional investors in the last quarter, including Balyasny Asset Management LLC, LMR Partners LLP and Harel Insurance Investments & Financial Services Ltd.. Company insiders that have bought MannKind Corporation stock in the last two years include Matthew J Pfeffer, Michael Castagna and Rosabel Realica Alinaya. View Insider Buying and Selling for MannKind Corporation.

How do I buy MannKind Corporation stock?

Shares of MannKind Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MannKind Corporation's stock price today?

One share of MannKind Corporation stock can currently be purchased for approximately $2.28.


MarketBeat Community Rating for MannKind Corporation (NASDAQ MNKD)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  201 (Vote Outperform)
Underperform Votes:  284 (Vote Underperform)
Total Votes:  485
MarketBeat's community ratings are surveys of what our community members think about MannKind Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for MannKind Corporation (NASDAQ:MNKD) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 1.67)
Consensus Price Target: $0.92 (59.87% downside)

Analysts' Ratings History for MannKind Corporation (NASDAQ:MNKD)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/1/2017Maxim GroupReiterated RatingBuyHighView Rating Details
5/22/2017J P Morgan Chase & CoReiterated RatingUnderweightHighView Rating Details
5/11/2017Piper Jaffray CompaniesSet Price TargetSell$1.00MediumView Rating Details
5/8/2017S&P Equity ResearchLower Price Target$1.04 -> $0.83HighView Rating Details
6/1/2016Royal Bank Of CanadaLower Price TargetUnderperform$1.00 -> $0.15N/AView Rating Details
4/28/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
4/1/2016Goldman Sachs Group, Inc. (The)Reiterated RatingSellN/AView Rating Details
1/6/2016Griffin SecuritiesUpgradeNeutral -> Buy$4.00N/AView Rating Details
11/14/2015Jefferies Group LLCReiterated RatingBuy$9.00N/AView Rating Details
(Data available from 9/19/2015 forward)

Earnings

Earnings History for MannKind Corporation (NASDAQ:MNKD)
Earnings by Quarter for MannKind Corporation (NASDAQ:MNKD)
Earnings History by Quarter for MannKind Corporation (NASDAQ MNKD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017        
8/7/2017Q2 2017($0.25)($0.35)$2.75 million$2.16 millionViewListenView Earnings Details
5/10/2017Q1 2017($0.09)($0.17)$3.50 million$3.00 millionViewN/AView Earnings Details
3/16/2017Q4 2016($0.20)($0.19)$6.00 million$12.40 millionViewN/AView Earnings Details
11/9/2016Q3 2016($0.06)$0.26$2.00 million$162.35 millionViewListenView Earnings Details
8/8/2016Q2($0.06)($0.07)$0.03 millionViewN/AView Earnings Details
5/9/2016Q116($0.04)($0.06)ViewN/AView Earnings Details
3/14/2016Q4($0.05)($0.66)$0.35 millionViewN/AView Earnings Details
11/9/2015Q315($0.07)($0.08)ViewN/AView Earnings Details
8/10/2015Q215($0.08)($0.07)$0.53 millionViewListenView Earnings Details
5/7/2015Q115($0.08)($0.08)$5.40 millionViewListenView Earnings Details
2/24/2015Q414($0.09)($0.09)$3.13 millionViewListenView Earnings Details
11/3/2014Q314$0.09($0.09)$66.60 millionViewListenView Earnings Details
8/11/2014Q214($0.11)($0.19)ViewListenView Earnings Details
5/12/2014Q114($0.13)($0.14)ViewListenView Earnings Details
2/18/2014Q4($0.14)($0.16)$0.43 millionViewListenView Earnings Details
11/4/2013Q313($0.14)($0.17)ViewListenView Earnings Details
8/9/2013Q2 2013($0.14)($0.16)ViewN/AView Earnings Details
5/9/2013Q1 2013($0.15)($0.15)ViewListenView Earnings Details
2/11/2013Q4 2012($0.19)($0.23)ViewListenView Earnings Details
11/1/2012Q312($0.24)($0.22)ViewN/AView Earnings Details
8/7/2012($0.24)($0.23)ViewN/AView Earnings Details
5/9/2012($0.23)($0.27)ViewN/AView Earnings Details
2/22/2012($0.32)($0.30)ViewN/AView Earnings Details
11/3/2011($0.32)($0.31)ViewN/AView Earnings Details
8/4/2011($0.30)($0.37)ViewN/AView Earnings Details
5/9/2011($0.29)($0.34)ViewN/AView Earnings Details
2/10/2011($0.40)($0.33)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MannKind Corporation (NASDAQ:MNKD)
Current Year EPS Consensus Estimate: $-1.09 EPS

Dividends

Dividend History for MannKind Corporation (NASDAQ:MNKD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for MannKind Corporation (NASDAQ:MNKD)
Insider Ownership Percentage: 1.60%
Institutional Ownership Percentage: 15.67%
Insider Trades by Quarter for MannKind Corporation (NASDAQ:MNKD)
Institutional Ownership by Quarter for MannKind Corporation (NASDAQ:MNKD)
Insider Trades by Quarter for MannKind Corporation (NASDAQ:MNKD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/10/2017Raymond W UrbanskiCMOSell296$1.15$340.40View SEC Filing  
6/30/2017Rosabel Realica AlinayaSVPBuy2,000$1.23$2,460.00View SEC Filing  
1/3/2017Matthew J PfefferCEOBuy4,540$0.54$2,451.60View SEC Filing  
1/3/2017Rosabel Realica AlinayaSVPBuy9,043$0.54$4,883.22View SEC Filing  
8/26/2016Michael CastagnaInsiderBuy17,500$0.78$13,650.00View SEC Filing  
8/24/2016Michael CastagnaInsiderBuy15,000$0.87$13,050.00View SEC Filing  
8/23/2016Michael CastagnaInsiderBuy25,000$0.94$23,500.00View SEC Filing  
8/15/2016Matthew J PfefferCEOBuy25,000$0.99$24,750.00View SEC Filing  
8/12/2016Michael CastagnaInsiderBuy25,000$1.00$25,000.00View SEC Filing  
5/17/2016Michael CastagnaInsiderBuy50,000$0.93$46,500.00View SEC Filing  
4/24/2015Hakan EdstromCEOSell73,460$4.83$354,811.80View SEC Filing  
3/27/2015Hakan EdstromCEOSell73,460$5.21$382,726.60View SEC Filing  
2/10/2015Hakan EdstromCEOSell73,460$7.75$569,315.00View SEC Filing  
2/5/2015David ThomsonVPSell80,000$7.00$560,000.00View SEC Filing  
1/5/2015Diane PalumboVPSell188,999$5.95$1,124,544.05View SEC Filing  
11/24/2014David ThomsonVPSell118,114$6.14$725,219.96View SEC Filing  
10/3/2014Juergen MartensVPSell63,800$5.48$349,624.00View SEC Filing  
8/27/2014Juergen MartensVPSell417$7.60$3,169.20View SEC Filing  
8/7/2014David ThomsonVPSell30,000$8.16$244,800.00View SEC Filing  
7/21/2014Juergen MartensVPSell26,458$9.65$255,319.70View SEC Filing  
7/15/2014Diane PalumboVPSell17,901$10.01$179,189.01View SEC Filing  
7/1/2014Matthew J PfefferCFOSell20,000$10.44$208,800.00View SEC Filing  
6/30/2014Hakan EdstromCOOBuy1,692$4.42$7,478.64View SEC Filing  
6/27/2014Juergen MartensVPSell25,417$10.53$267,641.01View SEC Filing  
6/26/2014David ThomsonVPSell30,000$10.51$315,300.00View SEC Filing  
6/20/2014Juergen MartensVPSell1,458$10.34$15,075.72View SEC Filing  
6/16/2014Diane PalumboVPSell17,902$10.59$189,582.18View SEC Filing  
6/5/2014Juergen MartensVPSell120,000$11.00$1,320,000.00View SEC Filing  
6/4/2014David ThomsonVPSell133,000$9.95$1,323,350.00View SEC Filing  
6/3/2014Diane PalumboVPSell52,957$9.50$503,091.50View SEC Filing  
5/23/2014Juergen MartensVPSell25,000$7.65$191,250.00View SEC Filing  
5/19/2014Juergen MartensVPSell76,899$7.50$576,742.50View SEC Filing  
5/15/2014Diane PalumboVPSell18,176$7.06$128,322.56View SEC Filing  
1/24/2014Juergen MartensVPSell50,000$5.56$278,000.00View SEC Filing  
12/31/2013Hakan EdstromCOOBuy1,589$4.53$7,198.17View SEC Filing  
12/20/2013Juergen MartensVPSell32,054$5.00$160,270.00View SEC Filing  
12/11/2013David ThomsonVPSell150,000$5.00$750,000.00View SEC Filing  
11/29/2013Juergen MartensVPSell48,057$5.01$240,765.57View SEC Filing  
11/15/2013Diane PalumboVPSell25,000$5.02$125,500.00View SEC Filing  
8/28/2013David ThomsonVPSell19,204$5.78$110,999.12View SEC Filing  
8/26/2013Juergen MartensVPSell20,000$5.52$110,400.00View SEC Filing  
8/1/2013Matthew J PfefferCFOSell10,000$8.00$80,000.00View SEC Filing  
7/2/2013Matthew J PfefferCFOSell10,000$7.00$70,000.00View SEC Filing  
6/30/2013Diane PalumboVPBuy1,610$1.96$3,155.60View SEC Filing  
6/30/2013Matthew J PfefferCFOBuy7,448$1.96$14,598.08View SEC Filing  
6/3/2013Diane PalumboVPSell66,849$7.50$501,367.50View SEC Filing  
5/16/2013Diane PalumboVPSell26,829$5.25$140,852.25View SEC Filing  
5/15/2013Matthew J PfefferCFOSell10,000$5.00$50,000.00View SEC Filing  
12/31/2012Matthew J PfefferCFOBuy1,056$1.95$2,059.20View SEC Filing  
12/21/2012Alfred E MannMajor ShareholderBuy40,000,000$2.59$103,600,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for MannKind Corporation (NASDAQ:MNKD)
Latest Headlines for MannKind Corporation (NASDAQ:MNKD)
Source:
DateHeadline
seekingalpha.com logoMannKind Puts Focus On Pipeline - Seeking Alpha
seekingalpha.com - September 14 at 9:08 PM
finance.yahoo.com logoWith MannKind Down Over 90%, NVIDIA Enables Nate Pile To Beat The Market
finance.yahoo.com - September 14 at 9:08 PM
seekingalpha.com logoMannKind: Their Technosphere Drug Delivery System - Hope Or Hype?
seekingalpha.com - September 14 at 7:51 AM
reuters.com logoBRIEF-MannKind says Raymond Urbanski, co's chief medical officer, informed co of his decision to resign
www.reuters.com - September 13 at 6:38 AM
seekingalpha.com logoMannKind (MNKD) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 13 at 6:38 AM
seekingalpha.com logoMannKind Corporation's (MNKD) CEO Michael Castagna Presents at Rodman & Renshaw 19th Annual Global ... - Seeking Alpha
seekingalpha.com - September 12 at 2:23 AM
seekingalpha.com logoMannKind - Afrezza Scripts Finish August Flat - Seeking Alpha
seekingalpha.com - September 10 at 3:00 AM
globenewswire.com logoMannKind Responds to Hurricane Harvey Devastation with Afrezza® Donation - GlobeNewswire (press release)
globenewswire.com - September 8 at 5:25 AM
finance.yahoo.com logoMannKind Responds to Hurricane Harvey Devastation with Afrezza® Donation
finance.yahoo.com - September 8 at 5:25 AM
finance.yahoo.com logoA Small Cap Stock Making Big Cap Waves
finance.yahoo.com - September 8 at 5:25 AM
finance.yahoo.com logoMannKind, Can Internal Sales Push Improve Adoption of Afrezza?
finance.yahoo.com - September 7 at 5:58 AM
globenewswire.com logoMannKind Corporation Relocates Headquarters to Westlake Village - GlobeNewswire (press release)
globenewswire.com - September 5 at 9:37 PM
finance.yahoo.com logoMannKind Corporation Relocates Headquarters to Westlake Village
finance.yahoo.com - September 5 at 4:34 PM
americanbankingnews.com logoMannKind Corporation (MNKD) Rating Reiterated by Maxim Group
www.americanbankingnews.com - September 4 at 2:32 PM
finance.yahoo.com logoMNKD Sep 2017 1.500 call
finance.yahoo.com - September 2 at 7:46 PM
seekingalpha.com logoMannKind: Afrezza Sales Bring In More Dollars; FDA Label Decision On Deck - Seeking Alpha
seekingalpha.com - September 2 at 6:18 AM
globenewswire.com logoMannKind Corporation to Present at Upcoming Conferences - GlobeNewswire (press release)
globenewswire.com - September 2 at 6:18 AM
finance.yahoo.com logoMannKind Corporation to Present at Upcoming Conferences
finance.yahoo.com - September 2 at 6:18 AM
finance.yahoo.com logo3 Stocks Capitalizing Off Positive Market Momentum On Wednesday
finance.yahoo.com - August 31 at 7:20 AM
seekingalpha.com logoMannKind - Scripts, Marketing, And Clinical Trials - Seeking Alpha
seekingalpha.com - August 26 at 8:07 PM
finance.yahoo.com logoMannKind Corporation (MNKD)
finance.yahoo.com - August 26 at 7:11 AM
finance.yahoo.com logoMNKD Aug 2017 1.500 put
finance.yahoo.com - August 19 at 2:20 AM
americanbankingnews.com logoFinancial Review: MannKind Corporation (MNKD) and Kura Oncology (KURA)
www.americanbankingnews.com - August 18 at 6:22 AM
finance.yahoo.com logoToday's Research Reports on Stocks to Watch: Biogen Inc. and MannKind Corporation
finance.yahoo.com - August 17 at 3:34 PM
nasdaq.com logoOptions Traders Expect Huge Moves in MannKind Corporation (MNKD) Stock - Nasdaq
www.nasdaq.com - August 15 at 2:01 AM
finance.yahoo.com logoOptions Traders Expect Huge Moves in MannKind Corporation (MNKD) Stock
finance.yahoo.com - August 15 at 2:01 AM
seekingalpha.com logoMannKind: Afrezza Scripts Dip As Analyst Initiates Coverage With $4 Price Target - Seeking Alpha
seekingalpha.com - August 14 at 12:15 AM
americanbankingnews.com logoZacks Investment Research Lowers MannKind Corporation (MNKD) to Sell
www.americanbankingnews.com - August 12 at 8:20 PM
americanbankingnews.com logoShort Interest in MannKind Corporation (NASDAQ:MNKD) Decreases By 5.7%
www.americanbankingnews.com - August 12 at 3:08 AM
seekingalpha.com logoMannKind Posts $35M Loss, Offers Guidance
seekingalpha.com - August 10 at 5:40 AM
finance.yahoo.com logo5 Things You'll Really Want to Know from MannKind's Q2 Update
finance.yahoo.com - August 10 at 5:40 AM
finance.yahoo.com logoEdited Transcript of MNKD earnings conference call or presentation 7-Aug-17 9:00pm GMT
finance.yahoo.com - August 10 at 5:40 AM
nasdaq.com logoEarnings Reaction History: MannKind Corp., 45.5% Follow-Through Indicator, 10.1% Sensitive - Nasdaq
www.nasdaq.com - August 9 at 12:35 AM
seekingalpha.com logoMannKind's (MNKD) CEO Matthew Castagna on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 9 at 12:35 AM
finance.yahoo.com logoMannKind Corporation (MNKD) Shares Up Despite Earnings Miss - Yahoo Finance
finance.yahoo.com - August 9 at 12:35 AM
investorplace.com logoMannKind Corporation (MNKD) Shares Up Despite Earnings Miss
investorplace.com - August 8 at 12:22 PM
fool.com logo5 Things You'll Really Want to Know from MannKind's Q2 Update
www.fool.com - August 8 at 7:44 AM
rttnews.com logoEARNINGS SUMMARY: Details of MannKind Corp. Q2 Earnings Report
www.rttnews.com - August 7 at 8:03 PM
finance.yahoo.com logoMannKind Corporation Reports 2017 Second Quarter Financial Results
finance.yahoo.com - August 7 at 8:03 PM
finance.yahoo.com logoMannKind reports 2Q loss
finance.yahoo.com - August 7 at 8:03 PM
americanbankingnews.com logoMannKind Corporation (MNKD) Releases Earnings Results, Misses Expectations By $0.11 EPS
www.americanbankingnews.com - August 7 at 5:14 PM
feeds.benzinga.com logoMannKind and One Drop Partner to Launch the A-ONE Clinical Trial
feeds.benzinga.com - August 7 at 10:25 AM
finance.yahoo.com logoMNKD Aug 2017 1.000 call
finance.yahoo.com - August 6 at 5:40 AM
finance.yahoo.com logoHow Bad Will MannKind Corporation's Q2 Results Look?
finance.yahoo.com - August 5 at 3:54 AM
fool.com logoHow Bad Will MannKind Corporation's Q2 Results Look?
www.fool.com - August 4 at 3:10 PM
seekingalpha.com logoMannKind: Afrezza Sales Spike, Giving Cautious Optimism - Seeking Alpha
seekingalpha.com - July 31 at 8:24 PM
americanbankingnews.com logoMannKind Corporation (NASDAQ:MNKD) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - July 31 at 9:00 AM
finance.yahoo.com logoMNKD Aug 2017 1.500 call
finance.yahoo.com - July 29 at 7:55 PM
globenewswire.com logoMannKind Corporation to Hold 2017 Second Quarter Financial Results Conference Call on August 7, 2017 - GlobeNewswire (press release)
globenewswire.com - July 26 at 12:35 AM
seekingalpha.com logoMannKind: Assessing The Insurance Landscape For Afrezza - Seeking Alpha
seekingalpha.com - July 26 at 12:35 AM

Social

Chart

MannKind Corporation (MNKD) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by MarketBeat.com Staff